AAAAAA

   
Results: 1-12 |
Results: 12

Authors: Andrews, JL Kadan, MJ Gorziglia, MI Kaleko, M Connelly, S
Citation: Jl. Andrews et al., Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII, MOL THER, 3(3), 2001, pp. 329-336

Authors: Jankova, L Harrop, SJ Saunders, DN Andrews, JL Bertram, KC Gould, AR Baker, MS Curmi, PMG
Citation: L. Jankova et al., Crystal structure of the complex of plasminogen activator inhibitor 2 witha peptide mimicking the reactive center loop, J BIOL CHEM, 276(46), 2001, pp. 43374-43382

Authors: Gallo-Penn, AM Shirley, PS Andrews, JL Tinlin, S Webster, S Cameron, C Hough, C Notley, C Lillicrap, D Kaleko, M Connelly, S
Citation: Am. Gallo-penn et al., Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogs, BLOOD, 97(1), 2001, pp. 107-113

Authors: Goetz, AS Andrews, JL Littleton, TR Ignar, DM
Citation: As. Goetz et al., Development of a facile method for high throughput screening with reportergene assays, J BIOMOL SC, 5(5), 2000, pp. 377-384

Authors: Skerritt, JH Hill, AS Andrews, JL
Citation: Jh. Skerritt et al., Antigenicity of wheat prolamins: Detailed epitope analysis using a panel of monoclonal antibodies, J CEREAL SC, 32(3), 2000, pp. 259-279

Authors: Roy, S Shirley, PS Connelly, S Andrews, JL Kayda, DB Gardner, JM Kaleko, M
Citation: S. Roy et al., In vivo evaluation of a novel epitope-tagged human factor VIII-encoding adenoviral vector, HAEMOPHILIA, 5(5), 1999, pp. 340-348

Authors: Andrews, JL Weaver, L Kaleko, M Connelly, S
Citation: Jl. Andrews et al., Efficient adenoviral vector transduction and expression of functional human factor VIII in cultured primary human hepatocytes, HAEMOPHILIA, 5(3), 1999, pp. 160-168

Authors: Gallo-Penn, AM Shirley, PS Andrews, JL Kayda, DB Pinkstaff, AM Kaloss, M Tinlin, S Cameron, C Notley, C Hough, C Lillicrap, D Kaleko, M Connelly, S
Citation: Am. Gallo-penn et al., In vivo evaluation of an adenoviral vector encoding canine factor VIII: High-level, sustained expression in hemophiliac mice, HUM GENE TH, 10(11), 1999, pp. 1791-1802

Authors: Gorelick, NJ Andrews, JL deBoer, JG Young, R Gibson, DP Walker, VE
Citation: Nj. Gorelick et al., Tissue-specific mutant frequencies and mutational spectra in cyclophosphamide-treated lacl transgenic mice, ENV MOL MUT, 34(2-3), 1999, pp. 154-166

Authors: Walker, VE Andrews, JL Upton, PB Skopek, TR deBoer, JG Walker, DM Shi, XC Sussman, HE Gorelick, NJ
Citation: Ve. Walker et al., Detection of cyclophosphamide-induced mutations at the Hprt but not the lacl locus in splenic lymphocytes of exposed mice, ENV MOL MUT, 34(2-3), 1999, pp. 167-181

Authors: Connelly, S Andrews, JL Gallo-Penn, AM Tagliavacca, L Kaufman, RJ Kaleko, M
Citation: S. Connelly et al., Evaluation of an adenoviral vector encoding full-length human factor VIII in hemophiliac mice, THROMB HAEM, 81(2), 1999, pp. 234-239

Authors: Bynum, J Andrews, JL Ellis, B Kull, FC Austin, EA Kilpatrick, KE
Citation: J. Bynum et al., Development of class-switched, affinity-matured monoclonal antibodies following a 7-day immunization schedule, HYBRIDOMA, 18(5), 1999, pp. 407-411
Risultati: 1-12 |